🔎 Trials Near Me

Domov › Rakovina prostaty › Utah

Klinické štúdie Rakovina prostaty v štáte Utah

24 štúdií pre Rakovina prostaty hľadá účastníkov v zariadeniach v štáte Utah.

Mestá v štáte Utah

Oficiálny text štúdie (anglicky)

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

  • Intermountain Medical Center, Murray
  • McKay-Dee Hospital Center, Ogden
  • LDS Hospital, Salt Lake City
  • a 2 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 2. 10. 2026 · NCT06931340

A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors

  • University of Utah - Huntsman Cancer Institute, Salt Lake City
  • START Mountain Region, West Valley City
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06465069

Study of AR Suppression With Carotuximab in Metastatic, Castration-Resistant Prostate Canc

  • Huntsman Cancer Institute and Hospital, Salt Lake City
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 30. 9. 2026 · NCT05534646

A Study of JNJ-98768111 in Participants With Advanced Prostate Cancer

  • START Mountain Region, West Valley City
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 25. 9. 2026 · NCT07746713

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

  • Utah Intermountain Medical Center, Murray
Prebieha náborFáza 2/3
Vek 18 až 100 · Muži · Aktualizované 22. 9. 2026 · NCT06780670

First-Time-in-Human Study of GSK5471713 in Adults With mCRPC

  • GSK Investigational Site, West Valley City
Prebieha náborFáza 1/2
Vek 18 a viac · Muži · Aktualizované 16. 9. 2026 · NCT07332455

Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy

  • Intermountain Health, Murray
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2026 · NCT06056830

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

  • American Fork Hospital / Huntsman Intermountain Cancer Center, American Fork
  • Sandra L Maxwell Cancer Center, Cedar City
  • Farmington Health Center, Farmington
  • a 9 ďalších
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 10. 9. 2026 · NCT05946213

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

  • Summit Urology, Murray
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 3. 9. 2026 · NCT07723248

AZD2265 Compared With Standard of Care in PSMA-positive Metastatic Castration-resistant Prostate Cancer (VECTRA-01)

  • Research Site, Salt Lake City
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 26. 8. 2026 · NCT07611110

Study of Oral MRT-2359 With Apalutamide in Prostate Cancer

  • START Mountain Region, West Valley City
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 24. 8. 2026 · NCT07745361

Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

  • Intermountain Medical Center, Murray
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 21. 8. 2026 · NCT04221542

Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 14. 7. 2026 · NCT06592924

Study of ORIC-944 in Patients With Metastatic Prostate Cancer

  • Huntsman Cancer Institute, University of Utah, Salt Lake City
Prebieha náborFáza 1
Vek 18 a viac · Muži · Aktualizované 9. 7. 2026 · NCT05413421

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

  • START Mountain Region, West Valley City
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 10. 6. 2026 · NCT07517198

Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer

  • Huntsman Cancer Institute/University of Utah, Salt Lake City
Prebieha náborFáza 2
Vek 18 a viac · Muži · Aktualizované 5. 6. 2026 · NCT05168618

Creatine Supplementation and Resistance Training to Preserve Muscle Mass and Attenuate Cancer Progression

  • Huntsman Cancer Institute, Salt Lake City
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 3. 6. 2026 · NCT06112990

Multimodal Telerehabilitation of Rural Patients With Advanced Prostate Cancer

  • Huntsman Cancer Institute at University of Utah, Salt Lake City
Prebieha nábor
Vek 18 a viac · Muži · Aktualizované 13. 4. 2026 · NCT07093177

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

  • START Center for Cancer Care - Mountain Region, Salt Lake City
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 27. 3. 2026 · NCT06395519

Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors

  • START, Mountain Region, West Valley City
Prebieha náborFáza 1/2
Vek 18 a viac · Všetky pohlavia · Aktualizované 17. 2. 2026 · NCT07145255

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Salt Lake City
Prebieha náborObservačná štúdia
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 28. 10. 2025 · NCT03452774

Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer

  • University of Utah Sugarhouse Health Center, Salt Lake City
  • Huntsman Cancer Institute/University of Utah, Salt Lake City
  • George E Wahlen Department of Veterans Affairs Medical Center, Salt Lake City
Prebieha náborFáza 3
Vek 18 a viac · Muži · Aktualizované 11. 9. 2025 · NCT03678025

Impact of Multimodal Telerehabilitation in Rural Patients With Metastatic Prostate Cancer

  • University of Utah Huntsman Cancer Institute, Salt Lake City
Prebieha nábor
Vek 21 a viac · Muži · Aktualizované 1. 8. 2025 · NCT07032584

Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.